Array Biopharma, Inc. (ARRY) Tops Q2 EPS by 4c

February 4, 2013 4:46 PM EST Send to a Friend
Get Alerts ARRY Hot Sheet
Trade ARRY Now!
Join SI Premium – FREE
Array Biopharma, Inc. (NASDAQ: ARRY) reported Q2 EPS of ($0.10), $0.04 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $18.4 million versus the consensus estimate of $16.52 million.

For earnings history and earnings-related data on Array Biopharma, Inc. (ARRY) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment